Drug Profile
Testosterone transdermal - Viramal
Alternative Names: TestoCream; VML-0403Latest Information Update: 07 Sep 2023
Price :
$50
*
At a glance
- Originator Viramal
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Androgen receptor agonists; Testosterone agonists; Testosterone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Hypogonadism
Highest Development Phases
- Phase III Hypogonadism
Most Recent Events
- 07 Sep 2023 Testosterone transdermal is still in phase III trials for Hypogonadism in USA
- 01 Oct 2019 No development reported - Phase-III for Hypogonadism in USA (Topical)
- 28 Jan 2019 Chemical structure information added